Peng Sun
Harbin Medical University(CN)China University of Mining and Technology(CN)Affiliated Hospital of Hebei University(CN)
Publications by Year
Research Areas
Pancreatic function and diabetes, Melanoma and MAPK Pathways, MicroRNA in disease regulation, Gene expression and cancer classification, Bioinformatics and Genomic Networks
Most-Cited Works
- → Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations(2012)2,783 cited
- → Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib(2014)2,623 cited
- → Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial(2012)539 cited
- → Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer(2015)507 cited
- → Overall Survival and Durable Responses in Patients With BRAF V600–Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib(2016)286 cited
- → Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial